Excipient FRCs

Pharmaceutical Excipient Functionality-Related Characteristics (FRCs)

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Introducing FRCs defined in USP/EP, physical testing methods (particle size, porosity, BET surface area), and their impact on tablet quality.

Key answer

Functionality-Related Characteristics (FRCs) are physical or chemical attributes of an excipient that, beyond default pharmacopeial chemical purity, dictate its physical performance (binding, disintegrating, sustained release) in formulation. Examples include particle size distribution and bulk density of microcrystalline cellulose (for flowability and hardness), crystallinity of lactose, or specific surface area (BET) of magnesium stearate (which affects mixing uniformity and tablet disintegration).

Physical Testing Methods for Common FRCs

Fluctuations in physical geometry lead to tablet capping or sticking during commercial manufacturing. Excipient sites should compile batch profiles for key FRCs.

  • Particle size distribution (PSD): testing D10, D50, D90 limits using laser diffraction
  • Specific surface area: using nitrogen adsorption (BET method) for porous binders
  • Powder flowability & bulk density: measuring angle of repose and Carr Index

FAQ

Are FRCs mandatory release tests in pharmacopoeias?+

Generally no. Pharmacopoeias (e.g., Ph. Eur. Clause 5.15) list them as informational, non-mandatory profiles. Different formulation processes (wet granulation vs. direct compression) require distinct physics, defined by specifications in Quality Agreements.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.